These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

937 related items for PubMed ID: 6888825

  • 1. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
    Franke HR, Risse EK, Kenemans P, Houx PC, Stolk JG, Vooijs GP.
    Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
    [Abstract] [Full Text] [Related]

  • 2. Human chorionic gonadotropin and free subunits' serum levels in patients with partial and complete hydatidiform moles.
    Berkowitz R, Ozturk M, Goldstein D, Bernstein M, Hill L, Wands JR.
    Obstet Gynecol; 1989 Aug; 74(2):212-6. PubMed ID: 2473429
    [Abstract] [Full Text] [Related]

  • 3. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG, Wielsma S, Massuger LF, Sweep FC, Thomas CM.
    Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
    [Abstract] [Full Text] [Related]

  • 4. Pre-evacuation hCG glycoforms in uneventful complete hydatidiform mole and persistent trophoblastic disease.
    Thomas CM, Kerkmeijer LG, Ariaens HJ, van der Steen RC, Massuger LF, Sweep FC.
    Gynecol Oncol; 2010 Apr; 117(1):47-52. PubMed ID: 20116088
    [Abstract] [Full Text] [Related]

  • 5. Hydatidiform mole and post-evacuation regression patterns of serum beta human chorionic gonadotrophin.
    Kamariah K, Satgunasingam N, Nasri NM, Ng KY.
    Med J Malaysia; 1993 Mar; 48(1):40-5. PubMed ID: 7688063
    [Abstract] [Full Text] [Related]

  • 6. An unusual clinical course after mole evacuation: a case report.
    Okamoto T, Nakanishi T, Nomura S, Goto S, Sakaida H, Tomoda Y.
    Nagoya J Med Sci; 1997 Mar; 60(1-2):49-52. PubMed ID: 9212649
    [Abstract] [Full Text] [Related]

  • 7. Earlier diagnosis and serum human chorionic gonadotropin regression in complete hydatidiform moles.
    Kerkmeijer LG, Massuger LF, Ten Kate-Booij MJ, Sweep FC, Thomas CM.
    Obstet Gynecol; 2009 Feb; 113(2 Pt 1):326-31. PubMed ID: 19155902
    [Abstract] [Full Text] [Related]

  • 8. Serum relaxin in patients with hydatidiform mole.
    Seki K, Uesato T, Tabei T, Kato K.
    Obstet Gynecol; 1986 Mar; 67(3):381-3. PubMed ID: 3945450
    [Abstract] [Full Text] [Related]

  • 9. Plasma prolactin, progesterone, estradiol, and human chorionic gonadotropin in complete and partial moles before and after evacuation.
    Ho PC, Wong LC, Ma HK.
    Obstet Gynecol; 1986 Jan; 67(1):99-106. PubMed ID: 3940346
    [Abstract] [Full Text] [Related]

  • 10. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S, Kerkmeijer L, Bekkers R, Pyman J, Tan J, Quinn M.
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
    [Abstract] [Full Text] [Related]

  • 11. Comparison of human chorionic gonadotropin +beta and invasive trophoblast antigen disappearance rates in serum after evacuation of molar pregnancy.
    Van Trommel NE, Sweep FC, Ross HA, Massuger LF, Thomas CM.
    Int J Mol Med; 2006 Oct; 18(4):705-11. PubMed ID: 16964426
    [Abstract] [Full Text] [Related]

  • 12. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
    Zhang WY, Yen GL.
    Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
    [Abstract] [Full Text] [Related]

  • 13. [Partial hydatidiform mole with significantly increased serum HCG levels in the triploidy syndrome].
    Arnholdt H, Elser H, Dörmer P.
    Geburtshilfe Frauenheilkd; 1984 May; 44(5):328-32. PubMed ID: 6565615
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Changes in serum human chorionic gonadotropin in patients with hydatidiform mole following evacuation].
    Wang X.
    Zhonghua Fu Chan Ke Za Zhi; 1988 Nov; 23(6):362-4, 388. PubMed ID: 2854773
    [No Abstract] [Full Text] [Related]

  • 16. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
    Niemann I, Vejerslev LO, Frøding L, Blaakær J, Maroun LL, Hansen ES, Grove A, Lund H, Havsteen H, Sunde L.
    Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
    [Abstract] [Full Text] [Related]

  • 17. Measurement of CA-125 in trophoblastic disease.
    Kohorn EI.
    Gynecol Oncol; 2000 Jul; 78(1):39-42. PubMed ID: 10873407
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Radioimmunoassay of beta sub unit HCG following hydatidiform mole or chorionic carcinoma (author's transl)].
    Tscherne G, Pürstner P.
    Geburtshilfe Frauenheilkd; 1979 Aug; 39(8):704-8. PubMed ID: 478273
    [Abstract] [Full Text] [Related]

  • 20. [HCG and SP1 in serum of patients with hydatidiform mole and chorionepithelioma--relative serum levels of both proteins in correlation to malignancy of the trophoblastic disease].
    Braun P, Leyendecker G.
    Arch Gynecol; 1979 Jul 20; 228(1-4):663-4. PubMed ID: 485549
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.